AltPep vs ProteoTech
AltPep
AltPep develops early disease-modifying treatments and detection tools for amyloid diseases
34 employees · est. 2019 · Seattle, United States
ProteoTech
Advancing Therapeutics and Diagnostics for Amyloid Diseases Since 1996
2-10 employees · est. 1996
ProteoTech is the older company (2019 vs 1996); AltPep is the larger of the two.
Side-by-Side Comparison
| Metric | AltPep | ProteoTech |
|---|---|---|
| Founded | ||
| Founded | 2019 | 1996 older |
| Headquarters | ||
| Headquarters | Seattle, United States | Not tracked yet |
| Employees | ||
| Employees | 34 larger | 2-10 |
| Industry | ||
| Industry | Biotechnology | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series B | Venture round |
| Total Funding | ||
| Total Funding | $78.10M | $10.54M |
| Funding Rounds | ||
| Funding Rounds | 3 | 2 |
| Services | ||
| Services | Development of diagnostics and therapeutics for amyloid diseases, Early detection and intervention for Alzheimer's and Parkinson's, Utilization of synthetic peptides for targeting b1-sheet toxic oligomers | Not tracked yet |
| Target Customers | ||
| Target Customers | Healthcare providers, Biopharmaceutical companies, Neurologists, Research institutions | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biomedical StartupDisease-modifying TreatmentsAmyloid DiseasesNeurodegenerative DiseasesType 2 DiabetesAlpha-sheet Protein Structure +5 | PharmaceuticalsTherapeuticsDiagnosticsAmyloid DiseasesAlzheimer's DiseaseParkinson's Disease +8 |
| Website | ||
| Website | altpep.com | proteotech.com |
About AltPep
AltPep is a biotechnology startup established in 2019, headquartered in the United States. The company specializes in developing early disease-modifying treatments and detection tools for amyloid diseases, focusing on toxic soluble oligomers, a key molecular trigger. This novel approach is backed by...
About ProteoTech
ProteoTech is a US-based pharmaceutical company founded in 1996, dedicated to advancing therapeutics and diagnostics for amyloid diseases. The company's product lineup includes Exebryl-1, which targets the prevention of beta-amyloid protein formation, PeptiClere for Alzheimer's treatment, Synuclere...
Also comparing in this category
Comparing more than these two?
Get AltPep, ProteoTech and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does AltPep compare?
A PDF of AltPep and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Frequently Asked Questions
Compare AltPep with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at AltPep on 12 Sep 2024, and ProteoTech on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
